221 related articles for article (PubMed ID: 31369867)
1. Performance of the Ankylosing Spondylitis Disease Activity Score based on a quick quantitative C-reactive protein assay in patients with axial spondyloarthritis.
Proft F; Muche B; Spiller L; Rios Rodriguez V; Rademacher J; Weber AK; Lüders S; Protopopov M; Redeker I; Spiller I; Sieper J; Poddubnyy D
Joint Bone Spine; 2020 Jan; 87(1):69-73. PubMed ID: 31369867
[TBL] [Abstract][Full Text] [Related]
2. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
Kilic E; Kilic G; Akgul O; Ozgocmen S
Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
[TBL] [Abstract][Full Text] [Related]
3. Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study.
Proft F; Schally J; Brandt HC; Brandt-Juergens J; Rüdiger Burmester G; Haibel H; Käding H; Karberg K; Lüders S; Muche B; Protopopov M; Rademacher J; Rios Rodriguez V; Torgutalp M; Verba M; Zinke S; Poddubnyy D
Ther Adv Musculoskelet Dis; 2022; 14():1759720X221085951. PubMed ID: 35368376
[TBL] [Abstract][Full Text] [Related]
4. Is there any gender-specific difference in the cut-off values of ankylosing spondylitis disease activity score in patients with axial spondyloarthritis?
Kilic G; Kilic E; Ozgocmen S
Int J Rheum Dis; 2017 Sep; 20(9):1201-1211. PubMed ID: 27309497
[TBL] [Abstract][Full Text] [Related]
5. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
Tsang HHL; Chung HY
J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
[TBL] [Abstract][Full Text] [Related]
6. Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore.
Kwan YH; Tan JJ; Phang JK; Fong W; Lim KK; Koh HL; Lui NL; Tan CS; Østbye T; Thumboo J; Leung YY
Int J Rheum Dis; 2019 Dec; 22(12):2206-2212. PubMed ID: 31721427
[TBL] [Abstract][Full Text] [Related]
7. Procollagen I N-terminal peptide correlates with inflammation on sacroiliac joint magnetic resonance imaging in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis: A cross-sectional study.
Li X; Liang A; Chen Y; Lam NS; Long X; Xu X; Zhong S
Mod Rheumatol; 2022 Jul; 32(4):770-775. PubMed ID: 34897520
[TBL] [Abstract][Full Text] [Related]
8. Performance characteristics of the simplified version of ankylosing spondylitis disease activity score (SASDAS).
Solmaz D; Yildirim T; Avci O; Tomas N; Akar S
Clin Rheumatol; 2016 Jul; 35(7):1753-8. PubMed ID: 26670454
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal Association Between Trabecular Bone Loss and Disease Activity in Axial Spondyloarthritis: A 4-year Prospective Study.
Kang KY; Ju JH; Park SH; Hong YS
J Rheumatol; 2020 Sep; 47(9):1330-1337. PubMed ID: 31732556
[TBL] [Abstract][Full Text] [Related]
10. [A study on calculating the ankylosing spondylitis disease activity score according to the C-reactive protein level].
Ji X; Du J; Zhu J; Huang F; Zhang J
Zhonghua Nei Ke Za Zhi; 2016 Mar; 55(3):206-10. PubMed ID: 26926373
[TBL] [Abstract][Full Text] [Related]
11. Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme.
Fernández-Espartero C; de Miguel E; Loza E; Tomero E; Gobbo M; Descalzo MA; Collantes-Estévez E; Mulero J; Muñoz-Fernández S; Zarco P; Carmona L;
Ann Rheum Dis; 2014 Jul; 73(7):1350-5. PubMed ID: 23709245
[TBL] [Abstract][Full Text] [Related]
12. Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis.
Salaffi F; Ciapetti A; Carotti M; Gasparini S; Citera G; Gutierrez M
Health Qual Life Outcomes; 2014 Aug; 12():129. PubMed ID: 25146299
[TBL] [Abstract][Full Text] [Related]
13. Calculating the ankylosing spondylitis disease activity score if the conventional c-reactive protein level is below the limit of detection or if high-sensitivity c-reactive protein is used: an analysis in the DESIR cohort.
Machado P; Navarro-Compán V; Landewé R; van Gaalen FA; Roux C; van der Heijde D
Arthritis Rheumatol; 2015 Feb; 67(2):408-13. PubMed ID: 25332195
[TBL] [Abstract][Full Text] [Related]
14. Equivalent cut-off values of Bath Ankylosing Spondylitis Disease Activity Index corresponding to Ankylosing Spondylitis Disease Activity Score cut-off values.
Cui R; Du Y; Tian N; Jiang HL; Tao YL; Dai SM
Clin Exp Rheumatol; 2023 May; 41(5):1163-1169. PubMed ID: 36226617
[TBL] [Abstract][Full Text] [Related]
15. Platelet to albumin ratio is an independent indicator for disease activity in ankylosing spondylitis.
Cui R; Wang YL; Tao YL; Tong Q; Chen Z; Dai SM
Clin Rheumatol; 2023 Feb; 42(2):407-413. PubMed ID: 36414863
[TBL] [Abstract][Full Text] [Related]
16. Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?
Georgiadis S; Ørnbjerg LM; Michelsen B; Kvien TK; Di Giuseppe D; Wallman JK; Závada J; Provan SA; Kristianslund EK; Rodrigues AM; Santos MJ; Rotar Ž; Perdan Pirkmajer K; Nordström D; Macfarlane GJ; Jones GT; van der Horst-Bruinsma I; Hellamand P; Østergaard M; Hetland ML
J Rheumatol; 2024 May; ():. PubMed ID: 38621792
[TBL] [Abstract][Full Text] [Related]
17. Gender difference in ASAS HI among patients with ankylosing spondylitis.
Chen HH; Chen YM; Lai KL; Hsieh TY; Hung WT; Lin CT; Tseng CW; Tang KT; Chou YY; Wu YD; Huang CY; Hsieh CW; Huang WN; Chen YH
PLoS One; 2020; 15(7):e0235678. PubMed ID: 32645080
[TBL] [Abstract][Full Text] [Related]
18. Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity.
Salaffi F; De Angelis R; Carotti M; Gutierrez M; Sarzi-Puttini P; Atzeni F
Rheumatol Int; 2014 Aug; 34(8):1103-10. PubMed ID: 24509896
[TBL] [Abstract][Full Text] [Related]
19. Construct validity of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) treatment target cut-offs in a BASDAI treat-to-target axial spondyloarthritis cohort: a cross-sectional study.
Michielsens C; Bolhuis TE; van Gaalen FA; van den Hoogen F; Verhoef LM; den Broeder N; den Broeder AA
Scand J Rheumatol; 2024 May; 53(3):180-187. PubMed ID: 37339375
[TBL] [Abstract][Full Text] [Related]
20. Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers.
Gentileschi S; Vitale A; Rigante D; Lopalco G; Emmi G; Orlando I; Di Scala G; Sota J; Fabiani C; Frediani B; Galeazzi M; Lapadula G; Iannone F; Cantarini L
Isr Med Assoc J; 2018 Jul; 20(7):438-441. PubMed ID: 30109794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
